Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 27 decisions over 12 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
8 Sep 2026
Director
Sold on a plan
20,000
$798.00K
31.8%
28 Aug 2026
President & Immunovant CEO
Sold on a plan
200,000
$7.15M
11.1%
27 Jul 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.99M
11.0%
30 Jun 2026
Director
Sold on a plan
10,000
$349.00K
18.9%
29 Jun 2026
Director
Sold on a plan
17,750
$610.25K
51.9%
24 Jun 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.63M
11.0%
22 May 2026
President & Immunovant CEO
Sold on a plan
200,000
$6.05M
11.0%
20 Apr 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.92M
10.8%
17 Mar 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.65M
10.8%
23 Feb 2026
President and Vant Chair
Sold on a plan
587,390
$16.16M
4.1%
20 Feb 2026
President and Vant Chair
Sold on a plan
1,012,610
$27.49M
6.9%
19 Feb 2026
President and Vant Chair
Sold on a plan
1,400,000
$38.39M
9.2%
13 Feb 2026
President & Immunovant CEO
Sold on a plan
200,000
$5.30M
10.8%
12 Jan 2026
President & Immunovant CEO
Sold on a plan
200,000
$4.38M
10.8%
9 Dec 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.17M
11.8%
7 Nov 2025
President & Immunovant CEO
Sold on a plan
200,000
$4.04M
11.7%
17 Oct 2025
President & Immunovant CEO
Sold on a plan
118,418
$2.02M
7.3%
16 Oct 2025
President & Immunovant CEO
Sold on a plan
318,282
$5.43M
17.5%
15 Oct 2025
President & Immunovant CEO
Sold on a plan
414,683
$7.02M
21.6%
13 Oct 2025
President & Immunovant CEO
Sold on a plan
20,727
$336.81K
1.4%
9 Oct 2025
President & Immunovant CEO
Sold on a plan
104,940
$1.71M
6.5%
8 Oct 2025
President & Immunovant CEO
Sold on a plan
138,602
$2.25M
8.4%
7 Oct 2025
President & Immunovant CEO
Sold on a plan
355,161
$5.74M
19.1%
6 Oct 2025
President & Immunovant CEO
Sold on a plan
171,396
$2.80M
10.2%
23 Sep 2025
President & Immunovant CEO
Sold on a plan
611,000
$9.06M
28.9%
22 Sep 2025
President & Immunovant CEO
Sold on a plan
416,182
$6.24M
16.4%
19 Sep 2025
President & Immunovant CEO
Sold on a plan
683,818
$10.22M
25.8%
Showing 1–27 of 27.